NCT03422783

Brief Summary

This study evaluates the correlation between NoL index response to standardized stimulus under general anesthesia and the post-operative pain, assessed by opioid consumption and numerical pain scores after video-assisted thoracoscopy (VATS).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

January 15, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 6, 2018

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

6.1 years

First QC Date

January 11, 2018

Last Update Submit

July 15, 2024

Conditions

Keywords

MonitoringBiomarkerThoracoscopy

Outcome Measures

Primary Outcomes (1)

  • Correlation between NoL index and Hydromorphone consumption H24

    Correlation between NoL index absolute values after electrical stimulus under general anesthesia and Total hydromorphone consumption (PACU and PCA) 24h after surgery

    Day 1 at 24 hours

Secondary Outcomes (27)

  • Pain scores (NRS) in PACU from 0 to 10

    Day 0 at hour 2

  • Correlation between NoL index and Pain scores (NRS from 0 to 10) in PACU

    Day 0 at hour 2

  • Pain scores (NRS from 0 to 10) at H24 at rest

    Day 1 at 24 hours

  • Correlation between NoL index and Pain scores (NRS) from 0 to 10 at H24 at rest

    Day 1 at 24 hours

  • Pain scores (NRS) at H24 while coughing from 0 to 10

    Day 1 at 24 hours

  • +22 more secondary outcomes

Study Arms (1)

Included patients

EXPERIMENTAL

There is only one arm in this study. Intervention will be electrical forearm stimulus under general anesthesia and the response of NOL index following this stimulus and its correlation with postoperative parameters such as pain and opioid consumption in post anesthesia care unit.

Device: Standardized tetanic stimulationDiagnostic Test: Catastrophizing scoreDiagnostic Test: Nociceptive thresholdBiological: Biomarkers

Interventions

The "intervention" is not a drug, but it is standardized electrical stimulus applied with a muscle relaxation monitor on the forearm of the anesthetized patient. The NoL index is registered in response to this stimulus in an observational manner. Device: Device PMD200TM offering intraoperative NoL Index

Included patients
Catastrophizing scoreDIAGNOSTIC_TEST

Pre-operative catastrophizing score is correlated with post-operative pain and opioid consumption

Included patients
Nociceptive thresholdDIAGNOSTIC_TEST

Nociceptive threshold for pressure, heat and electrical stimulation are associated with post-operative pain and will be assessed preoperatively to see if there is correlation between them and the NOL index response to the nociceptive stimulus (see intervention 1)

Included patients
BiomarkersBIOLOGICAL

Some biomarkers of inflammation and endogenous opioids are associated with post-operative pain. Blood samples will be withdrawn at D0 before surgery starts, D1 (H24) and D2 (H48) after surgery to see if they correlate with NOL changes after the stimulus described in intervention 1 above

Included patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient (Age 18 or older)
  • ASA status I, II or III
  • elective video assisted thoracoscopy under general anesthesia

You may not qualify if:

  • history of coronary artery disease
  • serious cardiac arrhythmia (including atrial fibrillation),
  • history of substance abuse,
  • chronic use of psychotropic and/or opioid drugs,
  • use of drugs that act on the autonomic nervous system (including β-blockers),
  • history of psychiatric diseases,
  • allergy to any drug used in the study protocol,
  • refusal of the patient
  • unexpected difficult airway requesting excessive, possibly painful airway manipulations
  • unexpected intraoperative complications requiring strong hemodynamic support (transfusions, vasopressors, inotropes)
  • conversion to thoracotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal

Montreal East, Quebec, H1T2M4, Canada

Location

MeSH Terms

Conditions

Pain, PostoperativeNociceptive Pain

Interventions

Biomarkers

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Biological Factors

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective Pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Research in the Department of Anesthesiology

Study Record Dates

First Submitted

January 11, 2018

First Posted

February 6, 2018

Study Start

January 15, 2018

Primary Completion

March 7, 2024

Study Completion

March 7, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations